agitg trial news

Trial Recruitment

AGITG Trial news: The AGITG currently has 10 studies open to recruitment and 10 studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Date of First Site Open (ANZ) Number of Sites Open  End of Recruitment 
ACME ABC (Biliary tract cancer) 40 50-75 23 February 2023 2 November 2024
ICEMELT (Pan Tumour) 228 250 9 December 2020 2 November 2025
iLSTA (Pancreatic cancer) 20 30 10 March 2023 1 December 2024
MASTERPLAN (Pancreatic cancer) 55 120 01 October 2019 17 December 2024
MASTERPLAN Microbiome (Pancreatic cancer) 16 60  July 2022 10 December 2024 
NEO-IMPACT (Pancreatic cancer) 19 20 13 May 2022 3 June 2024
OXTOX (Colorectal cancer) 65 100 18 December 2020 11 December 2024
PALEO (Oesophageal cancer) 18 54 3 December 2021 8 January 2026
RANDOMS (Pancreatic cancer) 22 60 14 December 2020 4 December 2024
RENO (Rectal cancer) 112 125 21 January 2019 10 January 2024
RESOLUTE  (Colorectal Cancer) 5 50 14 December 2021 10 February 2025
VADER (Colorectal cancer) 11 37 23 January 2023 9 June 2024

 

Share